U.S. Markets open in 1 hr 37 mins

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.60+0.02 (+1.27%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue158.333382175
Cost of Revenue---
Gross Profit158.333382175
Operating Expenses
Research Development41,454.45247,267.36123,138.05
Selling General and Administrative35,135.74536,609.62226,795.194
Non Recurring2,050.81710,142.7862,172.387
Total Operating Expenses81,901.05996,355.97653,451.286
Operating Income or Loss-81,742.726-95,973.976-53,276.286
Income from Continuing Operations
Total Other Income/Expenses Net-243.673,306.336-6,010.445
Earnings Before Interest and Taxes-81,720.602-91,938.482-58,720.112
Interest Expense---
Income Before Tax-81,720.602-91,938.482-58,720.112
Income Tax Expense2.42.45.3
Minority Interest-555.188-555.188-555.188
Net Income From Continuing Ops-81,723.002-91,940.882-58,709.064
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-81,723.002-91,940.882-58,630.19
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-81,723.002-91,940.882-58,630.19